Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Inflammatory involvement into phototoxic reaction in erythropoietic protoporphyria (EPP) patients.

Granata F, Duca L, Graziadei G, Brancaleoni V, Missineo P, De Luca G, Fustinoni S, Di Pierro E.

Immunol Res. 2019 Oct;67(4-5):382-389. doi: 10.1007/s12026-019-09097-5.

PMID:
31760565
2.

Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.

Russo G, De Franceschi L, Colombatti R, Rigano P, Perrotta S, Voi V, Palazzi G, Fidone C, Quota A, Graziadei G, Pietrangelo A, Pinto V, Ruffo GB, Sorrentino F, Venturelli D, Casale M, Ferrara F, Sainati L, Cappellini MD, Piga A, Maggio A, Forni GL.

Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0. Review.

3.

Access to emergency departments for acute events and identification of sickle cell disease in refugees.

De Franceschi L, Lux C, Piel FB, Gianesin B, Bonetti F, Casale M, Graziadei G, Lisi R, Pinto V, Putti MC, Rigano P, Rosso R, Russo G, Spadola V, Pulvirenti C, Rizzi M, Mazzi F, Ruffo G, Forni GL.

Blood. 2019 May 9;133(19):2100-2103. doi: 10.1182/blood-2018-09-876508. Epub 2019 Feb 11. No abstract available.

PMID:
30745303
4.

Oxygenation during general anesthesia and thoracic surgery in a patient with Titusville low-oxygen affinity hemoglobin.

Scaravilli V, Polli F, Mendogni P, Zanella A, Graziadei G, Pesenti A, Taccone P.

J Appl Physiol (1985). 2019 Apr 1;126(4):810-814. doi: 10.1152/japplphysiol.00860.2018. Epub 2019 Feb 7.

PMID:
30730815
5.

Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia.

Marktel S, Scaramuzza S, Cicalese MP, Giglio F, Galimberti S, Lidonnici MR, Calbi V, Assanelli A, Bernardo ME, Rossi C, Calabria A, Milani R, Gattillo S, Benedicenti F, Spinozzi G, Aprile A, Bergami A, Casiraghi M, Consiglieri G, Masera N, D'Angelo E, Mirra N, Origa R, Tartaglione I, Perrotta S, Winter R, Coppola M, Viarengo G, Santoleri L, Graziadei G, Gabaldo M, Valsecchi MG, Montini E, Naldini L, Cappellini MD, Ciceri F, Aiuti A, Ferrari G.

Nat Med. 2019 Feb;25(2):234-241. doi: 10.1038/s41591-018-0301-6. Epub 2019 Jan 21.

PMID:
30664781
6.

Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study.

Cappellini MD, Porter J, Origa R, Forni GL, Voskaridou E, Galactéros F, Taher AT, Arlet JB, Ribeil JA, Garbowski M, Graziadei G, Brouzes C, Semeraro M, Laadem A, Miteva D, Zou J, Sung V, Zinger T, Attie KM, Hermine O.

Haematologica. 2019 Mar;104(3):477-484. doi: 10.3324/haematol.2018.198887. Epub 2018 Oct 18.

7.

Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP).

Granata F, Mendez M, Brancaleoni V, Castelbon FJ, Graziadei G, Ventura P, Di Pierro E.

Mol Genet Metab. 2018 Nov;125(3):295-301. doi: 10.1016/j.ymgme.2018.09.002. Epub 2018 Sep 5.

PMID:
30201327
8.

Circulating cell-free DNA and ineffective erythropoiesis in nontransfusion-dependent β-thalassemia.

Tavazzi D, Motta I, Graziadei G, Sampietro M, Duca L, Cappellini MD.

Am J Hematol. 2018 Nov;93(11):E365-E368. doi: 10.1002/ajh.25248. Epub 2018 Sep 9. No abstract available.

9.

Digital PCR (dPCR) analysis reveals that the homozygous c.315-48T>C variant in the FECH gene might cause erythropoietic protoporphyria (EPP).

Brancaleoni V, Granata F, Missineo P, Fustinoni S, Graziadei G, Di Pierro E.

Mol Genet Metab. 2018 Aug;124(4):287-296. doi: 10.1016/j.ymgme.2018.06.005. Epub 2018 Jun 13.

PMID:
29941360
10.

Low-dose Synachten test with measurement of salivary cortisol in adult patients with β-thalassemia major.

Ambrogio AG, Danesi L, Baldini M, Radin R, Cassinerio E, Graziadei G, Mirra N, D'Angelo E, Marcon A, Mancarella M, Orsatti A, Bonetti F, Scacchi M, Cappellini MD, Persani L, Pecori Giraldi F.

Endocrine. 2018 May;60(2):348-354. doi: 10.1007/s12020-018-1562-z. Epub 2018 Mar 23.

11.

An unusual diagnosis in a 31-year-old man with abdominal pain and hyponatremia.

Depetri F, Cugno M, Graziadei G, Di Pierro E, Granata F, Peyvandi F, Cappellini MD.

Intern Emerg Med. 2018 Dec;13(8):1233-1238. doi: 10.1007/s11739-018-1826-x. Epub 2018 Mar 17. No abstract available.

PMID:
29550908
12.

Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula.

Dell'Arti L, Barteselli G, Riva L, Carini E, Graziadei G, Benatti E, Invernizzi A, Cappellini MD, Viola F.

PLoS One. 2018 Mar 1;13(3):e0193582. doi: 10.1371/journal.pone.0193582. eCollection 2018.

13.

What is behind a relapse of thrombotic thrombocytopenic purpura?

Capecchi M, Artoni A, Cappellini MD, Graziadei G.

Intern Emerg Med. 2018 Aug;13(5):709-712. doi: 10.1007/s11739-017-1764-z. Epub 2017 Nov 2. No abstract available.

PMID:
29094300
14.

Transcranial color Doppler in stroke-free adult patients with sickle cell disease.

Graziadei G, Casoni FM, Annoni F, Cortinovis I, Ridolfi P, Gandolfi I, Marcon A, Di Pierro E, Cappellini MD.

Ann Hematol. 2017 Sep;96(9):1547-1555. doi: 10.1007/s00277-017-3071-1. Epub 2017 Jul 20.

PMID:
28730452
15.

Decompensated Cirrhosis and Sickle Cell Disease: Case Reports and Review of the Literature.

D'Ambrosio R, Maggioni M, Donato MF, Lampertico P, Cappellini MD, Graziadei G.

Hemoglobin. 2017 Mar;41(2):131-133. doi: 10.1080/03630269.2017.1341420. Review.

PMID:
28696845
16.

Recommendations regarding splenectomy in hereditary hemolytic anemias.

Iolascon A, Andolfo I, Barcellini W, Corcione F, Garçon L, De Franceschi L, Pignata C, Graziadei G, Pospisilova D, Rees DC, de Montalembert M, Rivella S, Gambale A, Russo R, Ribeiro L, Vives-Corrons J, Martinez PA, Kattamis A, Gulbis B, Cappellini MD, Roberts I, Tamary H; Working Study Group on Red Cells and Iron of the EHA.

Haematologica. 2017 Aug;102(8):1304-1313. doi: 10.3324/haematol.2016.161166. Epub 2017 May 26.

17.

Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables.

Baldini M, Marcon A, Ulivieri FM, Seghezzi S, Cassin R, Messina C, Cappellini MD, Graziadei G.

Ann Hematol. 2017 Jun;96(6):995-1003. doi: 10.1007/s00277-017-2959-0. Epub 2017 Mar 20.

PMID:
28321531
18.

Pregnancy in β-thalassemia intermedia at two tertiary care centers in Lebanon and Italy: A follow-up report on fetal and maternal outcomes.

Roumi JE, Moukhadder HM, Graziadei G, Pennisi M, Cappellini MD, Taher AT.

Am J Hematol. 2017 Jun;92(6):E96-E99. doi: 10.1002/ajh.24690. Epub 2017 Mar 4. No abstract available.

19.

K. pneumoniae liver abscess following deferoxamine subcutaneous self-injection.

Furlan L, Graziadei G, Colombo G, Forzenigo LV, Solbiati M.

Am J Hematol. 2017 May;92(5):480-481. doi: 10.1002/ajh.24675. Epub 2017 Mar 10. No abstract available.

20.

Serum ferritin values between 300 and 800 ng/mL in nontransfusion-dependent thalassemia: A probability curve to guide clinical decision making when MRI is unavailable.

Saliba AN, Musallam KM, Cappellini MD, Graziadei G, Daar S, Viprakasit V, Taher AT.

Am J Hematol. 2017 Mar;92(3):E35-E37. doi: 10.1002/ajh.24628. Epub 2017 Feb 1. No abstract available.

21.

Chronic cholestasis in a patient with sickle-cell anemia: Histological findings.

D'Ambrosio R, Maggioni M, Graziadei G.

Dig Liver Dis. 2016 Nov;48(11):1402. doi: 10.1016/j.dld.2016.08.130. Epub 2016 Sep 8. No abstract available.

PMID:
27666963
22.

The assessment of noncoding variant of PPOX gene in variegate porphyria reveals post-transcriptional role of the 5' untranslated exon 1.

Fiorentino V, Brancaleoni V, Granata F, Graziadei G, Di Pierro E.

Blood Cells Mol Dis. 2016 Oct;61:48-53. doi: 10.1016/j.bcmd.2016.08.002. Epub 2016 Aug 17.

PMID:
27667166
23.

Ferroportin expression and regulation in non-transfusion dependent thalassemia.

Sonzogni L, Ronzoni L, Graziadei G, Cappellini MD.

Blood Cells Mol Dis. 2016 May;58:26-8. doi: 10.1016/j.bcmd.2016.02.004. Epub 2016 Feb 16. No abstract available.

PMID:
27067485
24.

Hemoglobin level and morbidity in non-transfusion-dependent thalassemia.

Taher AT, Musallam KM, Saliba AN, Graziadei G, Cappellini MD.

Blood Cells Mol Dis. 2015 Aug;55(2):108-9. doi: 10.1016/j.bcmd.2015.05.011. Epub 2015 May 30. No abstract available. Erratum in: Blood Cells Mol Dis. 2015 Dec;55(4):419. Garziadei, Giovanna [corrected to Graziadei, Giovanna].

PMID:
26142325
25.

X-chromosomal inactivation directly influences the phenotypic manifestation of X-linked protoporphyria.

Brancaleoni V, Balwani M, Granata F, Graziadei G, Missineo P, Fiorentino V, Fustinoni S, Cappellini MD, Naik H, Desnick RJ, Di Pierro E.

Clin Genet. 2016 Jan;89(1):20-6. doi: 10.1111/cge.12562. Epub 2015 Feb 17.

26.

The role of TMPRSS6 polymorphisms in iron deficiency anemia partially responsive to oral iron treatment.

Poggiali E, Andreozzi F, Nava I, Consonni D, Graziadei G, Cappellini MD.

Am J Hematol. 2015 Apr;90(4):306-9. doi: 10.1002/ajh.23929. Epub 2015 Mar 2.

27.

Growth Differentiation Factor 15 expression and regulation during erythroid differentiation in non-transfusion dependent thalassemia.

Ronzoni L, Sonzogni L, Duca L, Graziadei G, Cappellini MD, Ferru E.

Blood Cells Mol Dis. 2015 Jan;54(1):26-8. doi: 10.1016/j.bcmd.2014.08.006. Epub 2014 Aug 30. No abstract available.

PMID:
25179833
28.

Beta-thalassaemia intermedia: evaluation of endocrine and bone complications.

Baldini M, Marcon A, Cassin R, Ulivieri FM, Spinelli D, Cappellini MD, Graziadei G.

Biomed Res Int. 2014;2014:174581. doi: 10.1155/2014/174581. Epub 2014 Jul 7.

29.

Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study.

Musallam KM, Cappellini MD, Daar S, Karimi M, El-Beshlawy A, Graziadei G, Magestro M, Wulff J, Pietri G, Taher AT.

Haematologica. 2014 Nov;99(11):e218-21. doi: 10.3324/haematol.2013.097220. Epub 2014 Jul 4. No abstract available.

30.

Development of interactive algorithm for clinical management of acute events related to sickle cell disease in emergency department.

Forni GL, Finco G, Graziadei G, Balocco M, Rigano P, Perrotta S, Olivieri O, Cappellini MD, De Franceschi L.

Orphanet J Rare Dis. 2014 Jun 23;9:91. doi: 10.1186/1750-1172-9-91.

31.

Gaucher disease: a diagnostic challenge for internists.

Cassinerio E, Graziadei G, Poggiali E.

Eur J Intern Med. 2014 Feb;25(2):117-24. doi: 10.1016/j.ejim.2013.09.006. Epub 2013 Oct 1. Review.

PMID:
24090739
32.

Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase.

Ferru E, Pantaleo A, Carta F, Mannu F, Khadjavi A, Gallo V, Ronzoni L, Graziadei G, Cappellini MD, Turrini F.

Haematologica. 2014 Mar;99(3):570-8. doi: 10.3324/haematol.2013.084533. Epub 2013 Sep 13.

33.

Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: a closer look at the role of siderosis.

Maakaron JE, Cappellini MD, Graziadei G, Ayache JB, Taher AT.

Ann Hepatol. 2013 Jan-Feb;12(1):142-6. Review.

34.

Causes and correlates of anemia in 200 patients with acute cardiogenic pulmonary edema.

Rovellini A, Graziadei G, Folli C, Brambilla AM, Cosentini R, Canetta C, Monzani V.

Eur J Intern Med. 2012 Dec;23(8):733-7. doi: 10.1016/j.ejim.2012.06.012. Epub 2012 Jul 18.

PMID:
22818627
35.

Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients.

Cassinerio E, Roghi A, Pedrotti P, Brevi F, Zanaboni L, Graziadei G, Pattoneri P, Milazzo A, Cappellini MD.

Ann Hematol. 2012 Sep;91(9):1443-9. doi: 10.1007/s00277-012-1480-8. Epub 2012 May 10.

PMID:
22572843
36.

Does absolute excess of alpha chains compromise the benefit of splenectomy in patients with thalassemia intermedia?

Graziadei G, Refaldi C, Barcellini W, Cesaretti C, Cassinero E, Musallam KM, Cappellini MD.

Haematologica. 2012 Jan;97(1):151-3. doi: 10.3324/haematol.2011.046730. Epub 2011 Oct 11. No abstract available.

37.

Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.

Musallam KM, Cappellini MD, Wood JC, Motta I, Graziadei G, Tamim H, Taher AT.

Haematologica. 2011 Nov;96(11):1605-12. doi: 10.3324/haematol.2011.047852. Epub 2011 Jul 26.

38.

Porphyrias at a glance: diagnosis and treatment.

Cappellini MD, Brancaleoni V, Graziadei G, Tavazzi D, Di Pierro E.

Intern Emerg Med. 2010 Oct;5 Suppl 1:S73-80. doi: 10.1007/s11739-010-0449-7. Review.

PMID:
20865478
39.

Genetic variability of TMPRSS6 and its association with iron deficiency anaemia.

Delbini P, Vaja V, Graziadei G, Duca L, Nava I, Refaldi C, Cappellini MD.

Br J Haematol. 2010 Nov;151(3):281–4. doi: 10.1111/j.1365-2141.2010.08349.x.

PMID:
20738301
40.

Age-related complications in treatment-naïve patients with thalassaemia intermedia.

Taher AT, Musallam KM, El-Beshlawy A, Karimi M, Daar S, Belhoul K, Saned MS, Graziadei G, Cappellini MD.

Br J Haematol. 2010 Aug;150(4):486-9. doi: 10.1111/j.1365-2141.2010.08220.x. Epub 2010 Apr 29. No abstract available.

PMID:
20456362
41.

Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection.

Cosentini R, Tarsia P, Canetta C, Graziadei G, Brambilla AM, Aliberti S, Pappalettera M, Tantardini F, Blasi F.

Respir Res. 2008 May 30;9:48. doi: 10.1186/1465-9921-9-48.

42.

Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.

Castelli R, Cassinerio E, Cappellini MD, Porro F, Graziadei G, Fabris F.

Cardiovasc Hematol Disord Drug Targets. 2007 Sep;7(3):153-62. Review.

PMID:
17896955
43.

Intrathoracic masses due to extramedullary hematopoiesis.

Castelli R, Graziadei G, Karimi M, Cappellini MD.

Am J Med Sci. 2004 Nov;328(5):299-303.

PMID:
15545849
44.

Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes.

Tavazzi D, Duca L, Graziadei G, Comino A, Fiorelli G, Cappellini MD.

Br J Haematol. 2001 Jan;112(1):48-50.

PMID:
11167782
45.

Oral isobutyramide therapy in patients with thalassemia intermedia: results of a phase II open study.

Domenica Cappellini M, Graziadei G, Ciceri L, Comino A, Bianchi P, Porcella A, Fiorelli G.

Blood Cells Mol Dis. 2000 Feb;26(1):105-11.

PMID:
10772882
46.

Evaluation of spine and hip bone density by DXA and QCT in thalassemic patients.

Danesi L, Cherubini R, Ciceri L, Graziadei G, Cappellini MD, Cavagnini F, Ortolani S.

J Pediatr Endocrinol Metab. 1998;11 Suppl 3:961-2. No abstract available.

PMID:
10091172
47.

Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia.

Cappellini MD, Tavazzi D, Duca L, Graziadei G, Mannu F, Turrini F, Arese P, Fiorelli G.

Br J Haematol. 1999 Mar;104(3):504-12.

PMID:
10086787
48.

Nontransfusional iron overload in thalassemia intermedia: role of the hemochromatosis allele.

Cappellini MD, Fargion SR, Sampietro M, Graziadei G, Fiorelli G.

Blood. 1998 Dec 1;92(11):4479-80. No abstract available.

PMID:
9882096
49.

Butyrate trials.

Cappellini MD, Graziadei G, Ciceri L, Comino A, Bianchi P, Pomati M, Fiorelli G.

Ann N Y Acad Sci. 1998 Jun 30;850:110-9.

PMID:
9668533
50.

Plasmablastic lymphoma of the stomach. A case report.

Pruneri G, Graziadei G, Ermellino L, Baldini L, Neri A, Buffa R.

Haematologica. 1998 Jan;83(1):87-9.

Supplemental Content

Loading ...
Support Center